Isolation, Taxonomic Assignment, and Multi‐Assay Bioactivity Profiling of Sodaleptolyngbya sp. HX‐01 From Paddy Soil in Hoa Xuan
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.71868 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Santhosh Sigamani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pharmaceutical Biotechnology, College of Medicine and Pharmacy, Duy Tan University, Da Nang, Vietnam. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Cyanobacteria, Antineoplastic Agents. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Vietnam Academy of Science and Technology.
Abstract (Originalsprache)
The present research focuses on the isolation and characterization of a cyanobacterial strain identified as Sodaleptolyngbya sp. based on 16S rRNA gene sequencing and phylogenetic analysis. This cyanobacterium was cultivated under laboratory conditions, and the extracted volatile fraction of the metabolites was profiled by gas chromatography–mass spectrometry (GC–MS). Antibacterial potential was evaluated for six pathogenic bacteria, and its free radical scavenging activity was quantified. Cytotoxicity was evaluated using the MTT assay against four human cancer cell lines—HepG2 (liver), KB (oral epithelium), A549 (lung), and MCF‐7 (breast). To determine putative active principles, selected GC–MS constituents were docked in silico against the light‐independent protochlorophyllide reductase subunit B protein of Leptolyngbya boryana . Subsequently, their pharmacokinetic profiles were evaluated using absorption, distribution, metabolism, excretion, and toxicity (ADMET) criteria to assess drug‐likeness. The study identifies key biological characteristics and functional outcomes, thereby developing a robust soil‐to‐screen pipeline that efficiently expands the resource base for the identification of potential bioactive molecules. While these results are encouraging, we acknowledge the need for further in vitro and in vivo validation to confirm their anticancer and antimicrobial properties. Our findings suggest that these cyanobacterial metabolites may further add as an effective tool in the pharmaceutical sector.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Pharmaceutical Biotechnology, College of Medicine and Pharmacy, Duy Tan University, Da Nang, Vietnam.
- Computational Biology and Therapeutics Lab, Saveetha College of Physiotherapy, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, India.
- Faculty of Biotechnology, Vietnam National University of Agriculture, Hanoi, Vietnam.
- University of Science and Technology, The University of Da Nang, Da Nang, Vietnam.
- Hai Phong Branch (IOH), Institute of Oceanography, Vietnam Academy of Science and Technology (VAST), Hai Phong City, Vietnam.
ORCID-Profile: Santhosh Sigamani, Nguyen Huy Thuan, Saranyadevi Subburaj, Nguyen Thanh Trung
Förderung
- Vietnam Academy of Science and Technology
Zitieren
APA
Sigamani, S., Thuan, N. H., Subburaj, S., Trung, N. T., Canh, N. X., Bui, X., & Thu, P. T. (2026). Isolation, Taxonomic Assignment, and Multi‐Assay Bioactivity Profiling of Sodaleptolyngbya sp. HX‐01 From Paddy Soil in Hoa Xuan. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71868
Vancouver
Sigamani S, Thuan NH, Subburaj S, Trung NT, Canh NX, Bui X, et al. Isolation, Taxonomic Assignment, and Multi‐Assay Bioactivity Profiling of Sodaleptolyngbya sp. HX‐01 From Paddy Soil in Hoa Xuan. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71868
BibTeX
@article{Sigamani2026,
author = {Sigamani, Santhosh and Thuan, Nguyen Huy and Subburaj, Saranyadevi and Trung, Nguyen Thanh and Canh, Nguyen Xuan and Bui, XuanDong and Thu, Pham The},
title = {Isolation, Taxonomic Assignment, and Multi‐Assay Bioactivity Profiling of Sodaleptolyngbya sp. HX‐01 From Paddy Soil in Hoa Xuan},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.71868}
}
EUVIMED